Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs
- PMID: 3854
- DOI: 10.1126/science.3854
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs
Abstract
Tritiated haloperidol and tritiated dopamine label postsynaptic dopamine receptors in mammalian brain. Clinical potencies of butyrophenones, phenothiazines, and related drugs correlate closely with their ability to inhibit tritiated haloperidol binding. These binding methods provide a simple in vitro means for evaluating new drugs as potential antischizophrenic agents.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources